These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 12470802)

  • 1. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease.
    Robinson SR; Bishop GM
    Neurobiol Aging; 2002; 23(6):1051-72. PubMed ID: 12470802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amyloid hypothesis: let sleeping dogmas lie?
    Bishop GM; Robinson SR
    Neurobiol Aging; 2002; 23(6):1101-5. PubMed ID: 12470810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioflocculant hypothesis: a partial endorsement.
    Terry R
    Neurobiol Aging; 2002; 23(6):1075. PubMed ID: 12470804
    [No Abstract]   [Full Text] [Related]  

  • 4. Abeta conformational change is central to Alzheimer's disease.
    Holtzman DM
    Neurobiol Aging; 2002; 23(6):1085-8. PubMed ID: 12470806
    [No Abstract]   [Full Text] [Related]  

  • 5. Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions?
    Savory J; Ghribi O; Herman MM
    Neurobiol Aging; 2002; 23(6):1089-92. PubMed ID: 12470807
    [No Abstract]   [Full Text] [Related]  

  • 6. Testing times for the "amyloid cascade hypothesis".
    Hardy J
    Neurobiol Aging; 2002; 23(6):1073-4. PubMed ID: 12470803
    [No Abstract]   [Full Text] [Related]  

  • 7. Amyloid-beta: a (life) preserver for the brain.
    Obrenovich ME; Joseph JA; Atwood CS; Perry G; Smith MA
    Neurobiol Aging; 2002; 23(6):1097-9. PubMed ID: 12470809
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution and the scientific method.
    Tucker HM; Estus S
    Neurobiol Aging; 2002; 23(6):1093-5. PubMed ID: 12470808
    [No Abstract]   [Full Text] [Related]  

  • 9. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
    Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR
    Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities.
    Blass JP
    Neurobiol Aging; 2002; 23(6):1077-84. PubMed ID: 12470805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Amyloid Hypothesis in Alzheimer's Disease.
    Paroni G; Bisceglia P; Seripa D
    J Alzheimers Dis; 2019; 68(2):493-510. PubMed ID: 30883346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between amyloid-β and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease.
    Chuang JY; Lee CW; Shih YH; Yang T; Yu L; Kuo YM
    PLoS One; 2012; 7(3):e33120. PubMed ID: 22412990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.
    Wegiel J; Wang KC; Imaki H; Rubenstein R; Wronska A; Osuchowski M; Lipinski WJ; Walker LC; LeVine H
    Neurobiol Aging; 2001; 22(1):49-61. PubMed ID: 11164276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.
    Dodson SE; Andersen OM; Karmali V; Fritz JJ; Cheng D; Peng J; Levey AI; Willnow TE; Lah JJ
    J Neurosci; 2008 Nov; 28(48):12877-86. PubMed ID: 19036982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid β-peptide and Alzheimer's disease.
    Allsop D; Mayes J
    Essays Biochem; 2014; 56():99-110. PubMed ID: 25131589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
    Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
    Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nascent Aβ42 Fibrillization in Synaptic Endosomes Precedes Plaque Formation in a Mouse Model of Alzheimer's-like β-Amyloidosis.
    Eckman EA; Clausen DM; Solé-Domėnech S; Lee CW; Sinobas-Pereira C; Domalewski RJ; Nichols MR; Pacheco-Quinto J
    J Neurosci; 2023 Dec; 43(50):8812-8824. PubMed ID: 37884349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.